Compass Therapeutics Announces Issuance of Composition of Matter and Method Patents Covering Its Lead Immuno-oncology Candidate, CTX-471 by bizlift | Jun 17, 2019 | Compass Press Releases, Portfolio News
Twist Bioscience Launches Mouse Exome to Power Genetic Research by bizlift | Jun 17, 2019 | Portfolio News, Twist Press Releases
Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association by bizlift | Jun 15, 2019 | Editas Press Releases, Portfolio News
BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Health by bizlift | Jun 13, 2019 | BlackThorn Press Releases, Portfolio News
eGenesis Appoints Ariel Jasie as Chief Business Officer and General Counsel by bizlift | Jun 11, 2019 | eGenesis Press Releases, Portfolio News
Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of Brain Penetrant Enzyme Replacement Programs by bizlift | Jun 11, 2019 | Denali Press Releases, Portfolio News